Everforth Inc quarterly report, Q2 FY2002

Business Context and Reporting Period

Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2002
Business Overview: The Company operates in two segments: Lab Support (laboratory and scientific professionals) and Healthcare Staffing (medical billing, clinical lab, and travel nursing). The quarter was significantly impacted by the acquisition of Health Personnel Options Corporation ("HPO") on April 19, 2002.

Key Financial Metrics

Metric Three Months Ended June 30, 2002 Six Months Ended June 30, 2002
Revenues $67,600,000 $109,711,000
Net Income $3,874,000 $6,744,000
Diluted EPS $0.15 $0.27
Gross Margin 29.8% 30.7%
Operating Margin 9.2% 9.5%
Cash and Equivalents $34,511,000 (Balance Sheet Item)
Total Debt (Current + Long-term) $5,631,000 (Balance Sheet Item)
Working Capital $55,575,000 (Calculated)

Material Changes vs. Prior Period

  • Revenue Growth: Revenues increased 36.1% ($17.9M) for the quarter and 8.8% ($8.9M) for the six months compared to the prior year. This growth was driven primarily by the HPO acquisition, which contributed $27.6M in revenue for the period April 19 through June 30, 2002.
  • Organic Decline: Excluding the HPO acquisition, revenues actually decreased 19.4% for the quarter and 18.6% for the six months. The Lab Support segment saw a 21.2% revenue decline due to fewer temporary professionals on assignment and lower conversion fees.
  • Profitability: Net income decreased 14.0% for the quarter ($3.9M vs $4.5M) and 27.7% for the six months ($6.7M vs $9.3M) compared to the prior year, despite revenue growth, due to higher operating costs and lower interest income.
  • Balance Sheet Expansion: Total assets increased from $125.3M to $231.1M, largely due to $118.2M in goodwill recorded from the HPO acquisition. Cash and cash equivalents decreased from $65.7M to $34.5M due to acquisition costs.

Guidance, Outlook, and Risks

  • Outlook: Management expects Lab Support revenues to remain relatively flat for the remainder of the year. The Company anticipates that internally-generated cash and borrowing capacity will be sufficient to meet working capital needs.
  • Acquisition Integration: The HPO acquisition included an earn-out provision of up to $5.0M (cash and stock) contingent on meeting 2002 revenue targets. $2.5M of this is currently held in escrow.
  • Capital Expenditures: The Company is implementing a PeopleSoft enterprise system, expecting to incur $4M to $5M in capital expenditures over the next 16 months.
  • Debt Repayment: The Company repaid all bank debt outstanding as of June 30, 2002, in July 2002.
  • Risks: Key risks include the ability to attract and retain qualified staffing consultants, integration of acquired operations, and exposure to foreign currency fluctuations (though deemed immaterial).

Investor Verification Checklist

  • Acquisition Synergies: Verify if HPO is meeting the revenue targets required to trigger the $5.0M earn-out payment.
  • Organic Trends: Confirm the sustainability of the revenue decline in the core Lab Support segment (down ~21% organically).
  • Debt Obligations: Review the terms of the assumed HPO debt and the revolving line of credit, noting the recent repayment of prior debt in July 2002.
  • Goodwill Impairment: Monitor the $119.7M goodwill balance for potential future impairment, especially given the organic revenue headwinds in existing segments.
  • IT Implementation: Track the progress and cost overruns of the PeopleSoft implementation ($4M-$5M projected).
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.